{
AUT

Country

}
Raiffeisen Bank shares rise as market performance strengthens in 2024
Raiffeisen Bank International (RBI) has shown a strong performance in 2024, with shares priced at EUR 19.35, reflecting a 5.45% monthly increase and a 2.79% rise year-on-year. The bank is distributing a dividend of EUR 1.25 per share, and its market capitalization stands at EUR 6.4 billion. However, recent analyses indicate that shareholders may need to consider urgent actions regarding their investments.
aktiencheck.de
Euro Raiffeisen Bank International AG AUT
Finance & Economy, Market Report
03:16 22.12.2024
banking sector performance analysis highlights comebacks and declines in 2024
The latest performance report highlights significant variances across sectors, with PCB leading at 11.39% and consumer goods at 7.78%. In contrast, the automotive sector and telecoms show declines of -1.97% and -2.22%, respectively, while pharmaceuticals and energy face steep drops of -14.46% and -32.22%. In the banking sector, Commerzbank is rated positively, while Deutsche Bank is under observation due to high volatility. Year-to-date, Erste Group has surged by 60.3%, contrasting sharply with Sberbank's staggering -72.73% decline.
boerse-social.com
Euro United States Dollar Deutsche Bank RV Global PP The Goldman Sachs Group, Inc. Oberbank AG BNP Paribas SA HSBC HOLDINGS AMERICAN EXPRESS Erste Group Bank AG Societe Generale SA Credit Suisse Real Estate Fund Siat RBI OE TL.Z./Porsche AG Vz AAREAL BANK MTN.HPF.S259 JPMorgan Chase & Co. Banco Santander, S.A. AUT Show more
Finance & Economy, Market Report
13:23 21.12.2024
Raiffeisen investment yields 64.9 percent return over past decade
Investors who put €10,000 into Raiffeisen shares a decade ago would now hold 841.751 shares, valued at €16,489.90, reflecting a 64.90% increase from the initial investment. The share price was €11.88 ten years ago and is currently €19.59, with Raiffeisen's market capitalization reaching €6.43 billion.
finanzen.net
Euro Raiffeisen Bank International AG AUT
Finance & Economy, Market Report
21:02 20.12.2024
growth prospects in the food for special medical purpose market
The Food for Special Medical Purpose market is poised for growth, driven by the rise in chronic illnesses and an aging population, particularly in Asia Pacific and Europe. Key players include Nestle, Danone Nutricia, and Abbott, with significant investments in R&D despite high costs and regulatory challenges. The market focuses on tailored nutritional solutions for infants, adults, and the elderly, reflecting evolving dietary needs.
openPR.com
United States Dollar Fresenius Kabi AG Targeted Medical Pharma, Inc. Danone Nutricia SL Nestlé S.A. Bayer AG Ajinomoto Co., Inc. AUT CHE JPN ESP USA DEU Nidhi Bhawsar Show more
Healthcare, Market Report
18:18 20.12.2024
stock market performance and significant events on december 20
On December 20, 1989, Rath went public in Vienna, raising ATS 86 million. The ATX TR index saw an average performance of 0.16% on this date, with the best performance recorded in 2011 at 3.00% and the worst in 2018 at -2.73%. Additionally, Andritz replaced Raiffeisen in the ATX five on December 20, 2010.
boerse-social.com
Raiffeisen-Osteuropa-Rent Andritz AG Vienna International Airport AUT Dhruv Rathee Show more
Finance & Economy, Market Report
15:02 20.12.2024
Hackatao and Austrian Post Launch Innovative Crypto Stamp Art Collection
Hackatao has partnered with Austrian Post to launch Crypto Stamp Art, a limited-edition collection that merges art, history, and blockchain technology. Featuring designs inspired by Emperor Franz Joseph I and Empress Sisi, the collection includes 10,000 stamps with NFC chips for authenticity verification. This innovative project appeals to both traditional collectors and tech-savvy investors, redefining the concept of collectibles in the digital age.
Crypto News Flash
AUT Empress Elisabeth of Austria
Technology & Innovation, Press Release
13:00 20.12.2024
raiffeisen investment yields significant profit over ten years
Ten years ago, Raiffeisen shares closed at EUR 11.88, and an investment of EUR 10,000 would have yielded 841,751 shares. As of December 19, 2024, these shares are valued at EUR 16,489.90, reflecting a 64.90% increase in value, with the company’s market valuation at EUR 6.43 billion.
finanzen.at
Euro Raiffeisen Bank International AG AUT
Finance & Economy, Market Report
10:03 20.12.2024
raiffeisen shares see 64.90 percent growth over past decade
Investors who put EUR 10,000 into Raiffeisen shares a decade ago would now hold 841,751 shares, valued at EUR 16,489.90, reflecting a 64.90% increase. The market capitalization of Raiffeisen stands at EUR 6.43 billion, with the share price at EUR 19.59 as of December 19, 2024.
finanzen.ch
Euro Raiffeisen Bank International AG AUT
Finance & Economy, Market Report
09:33 20.12.2024
Raiffeisen Bank faces legal challenges as shares decline amid uncertainty
Raiffeisen Bank International (RBI) is poised for a critical ruling from a Russian court regarding a multi-billion dollar legal dispute, impacting its status as the largest western bank in Russia. The bank's shares closed at EUR 19.56 on December 19, reflecting a 0.64% decline, despite a positive monthly performance of 7.14%. With a market capitalization of EUR 6.4 billion and a dividend of EUR 1.25 for 2024, RBI remains a significant player in the European banking sector.
aktiencheck.de
Euro Raiffeisen Bank International AG RUS DEU AUT Show more
Finance & Economy, Market Report
03:13 20.12.2024
global uveitis treatment market poised for significant growth by 2032
The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
openPR.com
Pfizer Inc. Bayer AG Novartis AG Regeneron Pharmaceuticals, Inc. Merck & Co., Inc. CIPLA LTD Lupin Limited Hoffmann-La Roche AG Bausch Health Companies Inc. BIOGEN ABBVIE Alimera Sciences Inc. SAU ISR FRA RUS DEU TWN ARG ARE AUT TUR SGP NZL CHL USA BRA CAN ITA JPN IDN GBR ESP IND MYS COL AUS THA EGY VNM KOR PHL CHN ZAF MEX Nidhi Bhavsar Show more
Healthcare, Market Report
20:41 19.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Banking Regulations Central Bank Actions Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Mergers & Acquisitions Cryptocurrency Developments Blockchain Technology Adoption Cryptocurrency & Blockchain Regulations Market Analysis and Predictions Emerging Startups Anti-Money Laundering (AML) Regulations SEC & Financial Compliance Cryptocurrency Regulations Inflation Rates & CPI Data Banking & Investment Regulations
Countries:
USA CHE ARE DEU HKG AUS GBR JPN IND CHN SGP DNK CAN NGA FIN COL AUT TUR KOR ARG
Companies:
Credit Suisse Real Estate Fund Siat BlackRock, Inc. Coinbase Global, Inc. Solana USD Ethereum USD Fidelity Contrafund Tesla, Inc. Cardano USD Apple Inc. Ripples USD Grayscale Litecoin Trust NVIDIA Corporation MicroStrategy Inc Chainlink USD Google Inc. End Federal Reserve USD Amazon.com, Inc. Crypto.com Staked ETH USD Bitwise Bitcoin ETF Tether USDt CNY
Currencies:
United States Dollar Euro Swiss Franc Australian Dollar Japanese Yen Canadian Dollar Mozambican Metical Indian Rupee British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Thomas Jordan Michael J. Saylor Colm Kelleher Gary Gensler Alan Santana Paul Atkins Martin Schlegel Isabelle Chassot Mario Nawfal Sergio Ermotti Dana White Joe Rogan Bill Gates Fred Thiel

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.